Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

ExpreS2ion Biotech Holding AB: Publication of interim report for January – September 2019

ExpreS[2]ion Biotech Holding AB (“ExpreS[2]ion”) hereby publishes its interim report for the period January – September 2019. The report is available as an attached document to this press release and on the Company’s website (www.expres2ionbio.com). Below is a summary of the report.CEO Steen Klysner comments “I note with satisfaction that the positive development in revenues reported in the first half year is maintained in the third quarter and is accompanied by continued progress in both existing and new collaborations.” Third quarter (01/07/2019 to 30/09/2019) · Group turnover

Extraordinary General Meeting in Oncopeptides AB (publ)

The shareholders in Oncopeptides AB (publ), reg. no. 556596-6438, with registered office in the municipality of Stockholm, (“Oncopeptides” or the “Company”) are hereby given notice to attend an Extraordinary General Meeting to be held at Tändstickspalatset, Västra Trädgårdsgatan 15, Stockholm, Sweden, on Tuesday 17 December 2019 at 3.00 p.m. Coffee will be served starting at 2.30 p.m., at which time the registration for attendees will commence.Right to participate and notice Shareholders who wish to participate at the Extraordinary General Meeting must be entered in the share register of

Interim Report 3, 2019 - Continued strong organic growth and new CEO

Speqta AB (plc) Interim Report for quarter 3, 2019 has now been made public and is available at https://speqta.com/investors/financial-reports Significant events during the third quarter · Revenues during the third quarter increased by 98 % to KSEK 25,505 (12,888). · Adjusted EBITDA increased by 300 % to KSEK 4,435 (1,109), with an operating margin of 17 % (9). · EBITDA increased by 243 % to KSEK 3,804 (1,109), with an operating margin of 15% (9). · The segment Shopping, increased sales by 139% to KSEK 21,281 (8,914). EBITDA increased by 223% and amounted to KSEK 4,

Interim Report Q3 2019

Continued good margin and strong cash generationThird quarter 2019 · Revenue amounted to EUR 3,467 (4,919) thousand. · EBITDA amounted to EUR 1,867 (3,160) thousand. · Profit after tax was EUR 1,141 (2,034) thousand.  · Earnings per share after dilution amounted to EUR 0.015 (0.027). · New Depositing Customers (NDC) declined by 14%. · Cash flow from operating activities amounted to EUR 1,567 (3,454) thousand. Period 1 January– 30 September 2019 · Revenue amounted to EUR 11,017 (13,844) thousand. · EBITDA amounted to EUR 6,444 (9,245) thousand. · Profit

Terranet and Intel to Showcase Multi-Access Edge Computing (MEC) Demo at 5GAA Turin Conference

Today in Turin Italy, Terranet and Intel will jointly demonstrate a 4K streaming video application running over 5G networks utilizing Predictive Quality of Service (QoS) and Multi-Access Edge Computing (MEC).  The 5GAA In-Vehicle Entertainment (IVE) use case will be prominently featured as part of the C-V2X demos on display at the 5GAA conference, scheduled to take place in the Museo dell’Automobile.  Intel’s MEC technology serves as a key offering that promises cloud computing capabilities and an IT service environment at the edge of 5G mobile networks, both of which are critical to

Nanologica acknowledges World Diabetes Day

November 14 marks the date for the World Diabetes Day. For Nanologica, the day is highly relevant as the Company is working with solutions for diabetes related issues in both its business areas.Diabetes is a disease affecting more than 400 million people worldwide, a number that is expected to increase to more than 640 million by 2040. In 2015 diabetes was the cause of 5 million deaths and more than 200 million people are estimated to be affected by the disease without knowing it. Most diabetic patients require insulin to be able to survive, but as insulin is expensive, many cannot afford

Sale of shares in Solar A/S

Press release Copenhagen 14 November 2019 NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, CANADA, JAPAN OR AUSTRALIA OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. Chr. Augustinus Fabrikker A/S (“Augustinus”) has sold 600,000 B-shares in Solar A/S ("Solar"), representing 8.2% of the total number of shares and 3.9% of votes in Solar, through an accelerated bookbuilding to Danish and international institutional investors at a price of DKK 270 per share (the “Share Sale”). Due to strong demand the

Uppsala municipality chooses Tieto’s healthcare and welfare system to enable digitalization

Tieto has signed an agreement with Uppsala municipality to deliver a business system for its healthcare and welfare sections that will simplify everyday tasks for employees and help the municipality develop more digital services. Uppsala municipality chose Tieto Lifecare to replace several current systems used by more than 6,000 employees within the healthcare and social care sectors.Tieto Lifecare gives Uppsala municipality access to more efficient process support, a simpler user interface and new functionality for offering citizens more value-adding e-services. ”We want to use

CasinoGuideNJ.com launched in New Jersey

Net Gaming launches the local niche site CasinoGuideNJ.com, the first of several planned niche sites in the US market.“A niche site for New Jersey makes it easier for users to find the right iGaming operator, enabling us to drive traffic to our partners. Our goal is to launch more sites and build a position as one of the leading players in the US market,” comments Net Gaming CEO Marcus Teilman. Net Gaming owns and operates the global brand CasinoGuide.com which is also available in local versions in the UK and Germany.  For further information, please contact:Marcus Teilman,

Ahlstrom-Munksjö receives OK compost certification for its transparent packaging papers

AHLSTROM-MUNKSJÖ OYJ PRESS RELEASE November 14, 2019 at 9:00 A.M. EET Ahlstrom-Munksjö has received the OK compost HOME and OK compost INDUSTRIAL certifications from TÜV® Austria for its Cristal[TM] and Cristalline[TM] ranges of transparent papers. Whether used as transparent bread bags or paper window for fruits and vegetable sachets, Cristal[TM] and Cristalline[TM] product ranges are ideal materials to produce all-paper packaging solutions enabling consumers to quickly identify the products they buy. Made of responsibly-sourced natural fibers, these translucent papers are

Calmark publishes information memorandum in connection with fully guaranteed rights issue

Calmark Sweden AB (publ) (“Calmark” or “the Company”) is presenting an information memorandum today, on the occasion of the rights issue of units that Calmark’s extraordinary general meeting on 6 November 2019 resolved to conduct in accordance with the Board of Directors’s proposal (“the Rights issue”). If the Rights issue is fully subscribed, the Company is initially provided approximately MSEK 24.3 before issuance costs. On full exercise of all associated subscription warrants, the Company will receive between MSEK 10.3 and MSEK 16.2 additionally, before issuance costs. The Rights issue is

NENT Group launches BEAT Diabetes initiative and foundation

· NENT Group’s BEAT Diabetes initiative to focus on Health Tech, Healthy Lifestyles, and Inclusion & Wellbeing · NENT Group to invest at least SEK 2.5 million in BEAT Diabetes Foundation every year from 2020 · Over 1.5 million people living with diabetes across the Nordic region Nordic Entertainment Group (NENT Group), the Nordic region’s leading streaming company, today announced the launch of BEAT Diabetes, a long-term, pan-Nordic initiative to respond to the global diabetes challenge. NENT Group will also launch the BEAT Diabetes Foundation, an independent entity into which NENT

Successful improvements - Svenska Aerogel Holding AB (publ) increases efficiency and reduces use of resources

When transitioning to the new production line, MPP 2019, several improvements have been implemented to increase efficiency, quality and save resources. These projects have been very successful. Water consumtion at Svenska Aerogel plant in Gävle has been reduced by 75% and parts of the raw material usage have been reduced by 30%. This translates to increased productivity and reduces the environmental footprint.Svenska Aerogel's new production line MPP 2019 has been launched and extensive tests are now underway to ensure quality and function. This investment will enable Svenska Aerogel to

EATERIES IN THAILAND WIN MICHELIN STARS FOR 2020

SORN and R-HAAN in the Limelight as the First-Ever Traditional Thai Restaurants in the World to Earn a 2-MICHELIN-Star RatingMichelin today announced the winners of MICHELIN Star and Bib Gourmand distinctions; together with the official launch of the third edition of The MICHELIN Guide in Thailand, entitled The MICHELIN Guide Bangkok, Chiang Mai, Phuket & Phang-Nga 2020. Featured in this latest edition are 282 dining and 74 lodging establishments – with a total of 5 two-star, 24 one-star, and 94 Bib Gourmand eateries. Gwendal Poullennec, International Director of MICHELIN

IRRAS AB publishes Interim Report for the period January to September 2019

IRRAflow Gaining Traction in US ” Since the US is the world’s largest market for neurosurgical procedures, we have focused much of our team’s resources toward supporting a successful early market introduction. Response to our IRRAflow technology remains strong, and our sales funnel is full. Patient treatments with IRRAflow continued to increase, and multiple hospital systems moved from evaluating IRRAflow into the approval and purchasing phase.” Kleanthis G. Xanthopoulos, Ph.D., President and CEO of IRRAS   Third quarter, July – September 2019 · Net revenue amounted to SEK

Xspray Pharma publishes Interim Report Q3, January – September 2019

November 14, 2019  ”It is with a high pace, dedication and broad expertise that Xspray's team continued to drive the development of our furthest progressed product candidate, HyNap-Dasa, towards our first ANDA application. HyNap-Dasa is an amorphous version of Sprycel® (dasatinib). The target of submitting an application to the US FDA during the summer of next year remains firm, as is the planned market launch in the US of HyNap-Dasa in 2021” Per Andersson, CEO Xspray Pharma AB (publ)Significant events during the third quarter 2019 • Xspray announced that the company aims to up-

Pokerlistings.com opens casino vertical on new technical platform

Pokerlistings.com, Net Gaming’s most traffic-generating brand, has been moved to a new technical platform and also expanded to the casino vertical. The new platform gives Pokerlistings.com’s users an improved design with increased user-friendliness.Pokerlistings.com, which was founded in 2003, will now also drive traffic to casino operators. A special casino section of the website offers users guides to game rules, strategies and more for different casino games. Pokerlistings.com will also provide reviews of different online casinos and highlight operators’ offers to players. “The launch

Kesko’s sales grew in October

The sales of Kesko Group’s continuing operations in October 2019 totalled €993.5 million, representing an increase of 2.5% in comparable terms. Reported sales from continuing operations grew by 4.8%.“Reported sales grew in all divisions. Especially in the grocery trade sales growth continued strong,” says Mikko Helander, Kesko’s President and CEO. Sales in the grocery trade totalled €492.6 million in October, an increase of 4.6%. Sales grew in all chains. Sales in the building and technical trade totalled €415.7 million in October, a decrease of 0.4% in comparable terms in local

Inhalation Sciences Sweden AB (publ) releases Interim Report Q3 2019

Interim report in brief: Inhalation Sciences increased sales during the reporting period compared to the corresponding period last year by approx. 229 percent, contracted a CRO to conduct a clinical study of the PreciseInhale system, financed the clinical trial in its entirety through the sale of shares in the associated company Ziccum AB and, during the third quarter, recruited a new CEO: Mr. Manoush Masarrat.Selected financial data July-Sept 2019 Net sales 1,713 KSEK (715) Operating profit -2,747 KSEK (-2,684) Earnings per share before and after dilution SEK -0.36 (-0.31)

Boozt AB’s Q3 report, January 1 – September 30 2019

Net revenue growth of 22% (local currency 22%) in the third quarter with 19% growth in Boozt.com and 90% growth in Booztlet.com. The adjusted EBIT margin improved to -3.6% (-4.0%). For the first nine months net revenue growth was 26% (local currency 25%) with an adjusted EBIT margin of 0.3% (0.3%). CEO Hermann Haraldsson says: ““The softening of the apparel market, especially in Sweden and Denmark, increased over the summer which is reflected in the 19% growth of Boozt.com in the quarter. Booztlet.com however continued the strong trajectory with a 90% growth in the quarter. We are

Sustainability as the foundation for long term value creation

Sustainable forestry [UPM plants over 50 million trees annually.] UPM plants over 50 million trees annually. Sustainability as the foundation for long term value creation (UPM, Helsinki, 14 November 2019 at 9:00 EET) – Sustainability is the only solid foundation for long term value creation. This is the key message that UPM Communication Papers shares to international delegates at the 42nd FIPP World Media Congress, which is held from the 12th to 14th of November in Las Vegas. UPM is the main sponsor of the congress, which is the largest and most high-profile event in the

Interim report 1 January – 30 September 2019

RaySearch Laboratories AB (publ) “Following a record first half year, sales weakened in the third quarter. However, the market situation and demand for our products remain favorable and we have confidence in our strategy” Johan Löf, CEO of RaySearch.   THIRD QUARTER (JULY-SEPTEMBER 2019) ·Net sales SEK 144.3 M (150.5) ·Result after tax SEK -7.5 M (13.5) and earnings per share before/after dilution SEK -0.22 (0.39) ·Operating result SEK -6.3 M (12.4) ·Cash flow SEK -13.5 M (-17.0) ·Order intake SEK 196.8 M (175.7)  NINE MONTHS (JANUARY-

Consistently good quarter

The third quarter: July – September · Net sales increased 23 percent to 292.4 MSEK (237.7). · Order intake increased 57 percent to 199.3 MSEK (127.4). · Order backlog increased 29 percent to 1,556.9 MSEK (1,202.7). · Operating profit increased 25 percent to 31.3 MSEK (25.1). · Net profit after tax increased 21 percent to 23.2 MSEK (19.1). · Earnings per share increased 34 percent to 1.19 SEK (0.89) before and after dilution. · Operating cash flow amounted to -2.2 MSEK (33.1). The nine-month period: January – September · Net sales increased 18 percent to 887.3

Elekta’s Nomination Committee for the 2020 Annual General Meeting

STOCKHOLM, November 14, 2019 – In accordance with the resolution passed by Elekta’s (EKTA-B.ST) Annual General Meeting on August 22, 2019, the Chairman of the Board has convened the Nomination Committee for the 2020 Annual General Meeting by contacting the company’s largest shareholders in terms of votes, in addition to the shareholder or shareholders represented by the Chairman himself. The procedure is described in detail in the notice to the 2019 Annual General Meeting. The Nomination Committee consists of: · Laurent Leksell, in his capacity as Chairman of the Board of Elekta and

There are no items matching the current filter
There are no more items matching the current filter
Back to top